CBS inhibitors belong to a specific chemical class of compounds that have been meticulously designed to modulate the activity of cystathionine beta-synthase (CBS), an enzyme crucially involved in sulfur amino acid metabolism. CBS plays a significant role in catalyzing the condensation of homocysteine and serine to produce cystathionine, a pivotal step in the transsulfuration pathway that ultimately leads to the production of cysteine. These inhibitors are thoughtfully crafted molecules engineered to interact with CBS, influencing its normal function. Through these interactions, they might impact various cellular processes associated with sulfur amino acid metabolism, without directly altering its catalytic sites or its involvement in the biosynthesis of cysteine.
The design of CBS inhibitors is grounded in a comprehensive understanding of the structural and functional attributes of the enzyme. Typically developed using advanced chemical synthesis methods and informed by insights from enzymology and metabolic pathways, these inhibitors are characterized by their ability to selectively bind to CBS. This selectivity enables focused modulation of cellular pathways that rely on the activity of this specific enzyme. The development and utilization of CBS inhibitors contribute to advancing our understanding of the complex interplay between metabolic processes and cellular responses, offering insights into the fundamental molecular mechanisms that govern sulfur amino acid metabolism, redox balance, and the synthesis of essential biomolecules in various organisms.
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Rimonabant Hydrochloride | 158681-13-1 | sc-212786 | 10 mg | $163.00 | 1 | |
A selective CB1 antagonist, used for weight loss and smoking cessation, thought to reduce appetite and craving by blocking CB1 receptors in the brain. Due to psychiatric side effects, it was withdrawn from the market in some countries. | ||||||
AM-630 | 164178-33-0 | sc-200365B sc-200365 sc-200365A sc-200365C | 5 mg 10 mg 50 mg 100 mg | $76.00 $163.00 $622.00 $852.00 | 8 | |
A selective CB2 antagonist, used to study the role of CB2 receptors in immune response modulation and inflammation. | ||||||
SR 144528 | 192703-06-3 | sc-224292 sc-224292A | 5 mg 10 mg | $282.00 $539.00 | 6 | |
A highly selective CB2 antagonist, useful for investigating the role of CB2 receptors in various biological processes, particularly immune function. | ||||||
(±)-SLV 319 | 362519-49-1 | sc-222317 sc-222317A | 1 mg 5 mg | $30.00 $131.00 | ||
A selective CB1 antagonist, studied for its potential in obesity management, though its development was not as advanced as rimonabant's. | ||||||
JTE 907 | 282089-49-0 | sc-203616 sc-203616A | 10 mg 50 mg | $283.00 $1100.00 | ||
JTE-907 is a selective CB2 antagonist that has been studied for its potential anti-inflammatory and immunomodulatory effects by targeting CB2 receptors. | ||||||
O-1918 | 536697-79-7 | sc-202746 sc-202746A | 1 mg 5 mg | $60.00 $230.00 | ||
O-1918 is an example of a non-selective CB1/CB2 antagonist that has been used to study the effects of endocannabinoid system modulation. | ||||||
NESS 0327 | 494844-07-4 | sc-222054 sc-222054A | 1 mg 5 mg | $316.00 $1270.00 | 1 | |
NESS0327 is a CB2 receptor antagonist that has been investigated for its role in immune response and inflammation modulation. |